Tag: Schizophrenia

Finding myself intrigued by this man who'd never trained in psychiatry or psychology but who nevertheless worked effectively with people in severe distress using self-developed theories, I tracked Buhner down. I asked him to speak to me about these issues, and here is what resulted.

Association found between long-term antipsychotic use and poorer performance on cognitive tasks in adults diagnosed with ‘schizophrenia.’

The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common.

After working in the field, I have found that the majority of people in the mental health system are not getting adequate care like I received during my first psychotic episode. I was lucky enough to have a doctor who took a nontraditional approach to schizophrenia and worked with me on coming off of medications.

In this interview we will explore often-contentious topics including the non-validity of the biological model, the link between parenting problems and psychosis, and how best to help psychotic people who are fighting both emotional conflicts and a psychiatric system drugging them into silence.

I believe that an Intensive Psychotherapy can lead to healing and, often, a cure of psychotic states. By cure I mean the cessation of delusions and hallucinations, and a gradual titration off of antipsychotic medication, with the cure lasting—even without continuing psychotherapy.

A new review, published in Schizophrenia Bulletin, examines the effects of exercise on cognition in individuals diagnosed with 'schizophrenia.' The results of the meta-analysis...

In a recently published commentary in Psychiatric Times, Ronald Pies and Joseph Pierre made this assertion: Only clinicians, with an expertise in assessing the research literature, should be weighing in on the topic of the efficacy of psychiatric drugs. They wrote their commentary shortly after I had published on madinamerica “The Case Against Antipsychotics,” and it was clear they had me in their crosshairs.

Long-term treatment with antipsychotic drugs is currently considered the standard treatment for patients diagnosed with ‘schizophrenia.’ A new study challenges this practice, however. The...

This review of the scientific literature, stretching across six decades, makes the case that antipsychotics, over the long-term, do more harm than good. The drugs lower recovery rates and worsen functional outcomes over longer periods of time.

Over the past twenty years, the number of prescriptions for atypical antipsychotics written to children and young adults between four and eighteen has increased...

In the first study of its kind, researchers from Finland found the “most definitive evidence to date” that smoking during pregnancy is associated with the eventual diagnosis of schizophrenia in offspring. After controlling for other potential variables, the study, published ahead of print in The American Journal of Psychiatry, revealed a 38% increased odds of developing symptoms diagnosed as schizophrenia in young adults who were exposed to high levels of nicotine in utero.

The producers of “Healing Voices” ­‐ a new social action documentary about mental health ­‐ are releasing the film via community screening partners in...

Richard Bentall and David Pilgrim offer their critique of genetic theories of schizophrenia for the Conversation. "The high heritability estimates reported in earlier quantitative...

In an exchange published in the Journal of Clinical Epidemiology, researchers take turns highlighting major problems in the way psychiatry is currently practiced in the United States. In response to an article by Vinay Prasad calling for an insistence on randomized control trials in “evidence-based” medicine, Jose de Leon, from the Mental Health Research Center at the University of Kentucky begins the back-and-forth by pointing out that this type of evidence has been detrimental to the field of mental health.

Jim van Os, professor of Psychiatric Epidemiology at Maastricht University and member of the Royal Dutch Academy of Science with more than 700 publications, is one of the top one percent highly cited scientists in the world.

From the Daily Beast: "Amphetamines come with a host of negative side effects, most commonly insomnia and irregular heartbeat. But in less common cases, the...

What is schizophrenia? According to the website of the National Institute of Mental Health (NIMH), schizophrenia is a chronic, severe, incurable, and disabling brain disorder that affects about 1% of Americans today. Its cause is unknown but most experts assume it is genetic. According to E. Fuller Torrey, the founder and Executive Director of the Stanley Medical Research Institute and a high-profile schizophrenia researcher, “schizophrenia is caused by changes in the brain and ... these can be measured by changes in both brain structure and brain function. … Schizophrenia is thus a disease of the brain in exactly the same sense that Parkinson’s disease, multiple sclerosis, epilepsy, and Alzheimer’s disease are diseases of the brain.” Behind this confident rhetoric lies a heated controversy.

For Slate, Eliezer Sternberg outlines research suggesting that auditory hallucinations are actually “subvocal speech” produced by the patient themselves. When a schizophrenic patient hears...

Last week, the headlines blared: "Schizophrenia breakthrough as genetic study reveals link to brain changes!"  We heard that our best hope for treating “schizophrenia” is to understand it at a genetic level, and that this new breakthrough would get us really started on that mission, as it showed how a genetic variation could lead to the more intense pruning of brain connections, which is often seen in those diagnosed with schizophrenia.  “For the first time, the origin of schizophrenia is no longer a complete black box,” said one (while admitting that "it's still early days").  The acting director of the National Institute of Mental Health (NIMH) described the study as “a crucial turning point in the fight against mental illness.” But is all this hype justified?

Another scientific study that ostensibly identifies a biological cause of schizophrenia has appeared and is being widely reported. So, we finally have the elusive breakthrough to understanding the biological basis of schizophrenia. Or do we? A close look at the source of all this hyperbolic language raises serious questions about such enthusiasm.

Families are often very important for people encountering severe mental and emotional difficulties. But how can family members really know what is helpful, and what is likely to make things worse for the person having problems? Similarly, for those who want to help families, how can they know what will really be helpful for those families, and what will make things worse?

In a featured article for Psychiatric Services, psychiatrists from Dartmouth raise the alarm on the increasing numbers of children prescribed dangerous antipsychotic drugs. Despite the fact that data on the safety of long-term use of these drugs in this vulnerable population “do not exist,” the rate of children and adolescents being prescribed antipsychotic drugs have continued to increase over the past fifteen years.

Readers respond to the New York Times article, “The Treatment of Choice,” about innovative programs for psychosis and schizophrenia that involve patients and their families in treatment decisions. “Narratives of success counter a drumbeat of faulty links of mental illness and violence, inaccuracies which serve only to further stigmatize and isolate individuals with psychiatric illness.”

The German news agency DW features a video report on whether cannabidiol, an active substance derived from marijuana, can help relieve the symptoms of schizophrenia.